Potent graft-versus-leukemia effect in BCR/ABL negative chronic myelogenous leukemia

被引：1

作者：

Holtick, Udo

Marshall, Scoff R.

O'Brien, Stephen G.

Collin, Matthew P.

机构：

来源：

BLOOD | 2007年 / 110卷 / 13期

关键词：

D O I：

10.1182/blood-2007-09-111757

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4622 / 4623

页数：2

共 9 条

[1] Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8 [J].

Andersen, MK ;

Pedersen-Bjorgaard, J ;

Kjeldsen, L ;

Dufva, IH ;

Brondum-Nielsen, K .

LEUKEMIA, 2002, 16 (07) :1390-1393

[2] Specific human cellular immunity to bcr-abl oncogene-derived peptides [J].

Bocchia, M ;

Korontsvit, T ;

Xu, Q ;

Mackinnon, S ;

Yang, SY ;

Sette, A ;

Scheinberg, DA .

BLOOD, 1996, 87 (09) :3587-3592

[3] Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation [J].

Bornhauser, M. ;

Thiede, C. ;

Babatz, J. ;

Schetelig, J. ;

Illmer, T. ;

Kiani, A. ;

Platzbecker, U. ;

Herr, W. ;

Rieber, E. -P. ;

Ehninger, G. ;

Schmitz, M. .

LEUKEMIA, 2006, 20 (11) :2055-2057

[4]

CORTES JE, 1995, CANCER-AM CANCER SOC, V75, P464, DOI 10.1002/1097-0142(19950115)75:2<464::AID-CNCR2820750209>3.0.CO

[5]

2-E

[6] Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia:: a report of nine cases and analysis of predictive factors [J].

Lin, Yulia ;

Bruyere, Helene ;

Horsman, Douglas E. ;

Pantzar, Tapio ;

Barnett, Michael J. ;

Hogge, Donna E. ;

Nevill, Thomas J. ;

Nantel, Stephen H. ;

Sutherland, Heather J. ;

Toze, Cynthia L. ;

Shepherd, John D. ;

Lavoie, Julye C. ;

Song, Kevin W. ;

Smith, Clayton A. ;

Forrest, Donna L. .

CANCER GENETICS AND CYTOGENETICS, 2006, 170 (01) :16-23

[7] Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia [J].

Mittal, P ;

Saliba, RM ;

Giralt, SA ;

Shahjahan, M ;

Cohen, AI ;

Karandish, S ;

Onida, F ;

Beran, M ;

Champlin, RE ;

de Lima, M .

BONE MARROW TRANSPLANTATION, 2004, 33 (10) :1005-1009

[8] PH-NEGATIVE AND BCR-NEGATIVE ATYPICAL CHRONIC MYELOGENOUS LEUKEMIA - BIOLOGICAL FEATURES AND CLINICAL OUTCOME [J].

MONTEFUSCO, E ;

ALIMENA, G ;

LOCOCO, F ;

DECUIA, MR ;

WANG, YZ ;

SPIRITI, MAA ;

MANCINI, F ;

CEDRONE, M ;

MANCINI, M ;

MANDELLI, F .

ANNALS OF HEMATOLOGY, 1992, 65 (01) :17-21

[9] Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses [J].

Pinilla-Ibarz, J ;

Cathcart, K ;

Korontsvit, T ;

Soignet, S ;

Bocchia, M ;

Caggiano, J ;

Lai, L ;

Jimenez, J ;

Kolitz, J ;

Scheinberg, DA .

BLOOD, 2000, 95 (05) :1781-1787

← 1 →